Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.
Very well thanks Ivy - I don't swing by very often, but then I always knew this was likely to be a 5-10 year investment in Motif to see the real value. I've added a good few ISA years in this stock for my wife and I though, so definitely committed!
Hope all is well (other than your reds getting done last night that is!) ;)
Hi everyone - it feels like so long ago this story started, but what a journey and today is the most significant step so far. I've believed in Motif ever since I first researched it and saw the potential, along with the problem it is part of the solution for.
Best to everyone and we can finally start seeing the attention coming into this share. The valuation has never reflected what we have got, and I don't think it will just magically do so overnight either - but we're so far away from our similar stage peers.
Bring it on! The next 3-5 years should see some real strong value come in here and I won't be letting go of a single share unless something really goes wrong which it hasn't so far!
Hi fellow Motif investors. AIM is a notoriously high risk market where speculative companies come on and investors love the addiction of fast moves and the rush of profits, or low of losses. So when I first met Graham in Feb (I think!) 2015 and heard about Motif I was genuinely surprised. This was not your ordinary AIM stock with a fairly unique set of circumstances (which you'll all be familiar with) that drove them on a hard timeframe and forced their hand into AIM.
Despite the clear quality against other stock, they've not found their AIM journey any easier than others, and their cap still has huge disparity with comparable's. It's not been without risk for investors, although it's about as safe a bet as you get on AIM.
I came into the IPO with a not insubstantial holding and have only ever added since during weakness. I'm no longer involved actively in investing and managing my portfolio, as I've had my own business that I've been focusing on growing. I forget some of the shares I hold! I've never forgotten Motif though, and it's pretty much the only one I will check up on every now and again.
It's hard to believe that next Feb will be 4 years on since I first met both Graham and his company, and we'll have an FDA decision which looks no less certain to me than it did 4 years ago. There's tremendous value lying dormant here and whilst they will still have to commercialise it, it's hard not to see LTHs have huge rewards on the table. Short-ish term we'll have those FDA results (13th Feb) that will provide uplift, but I suspect given the shares history it will be the commercialisation deal on one or multiple markets that truly see the SP value added to.
And I will still be there holding my shares, because unless something drastic changes, I only see the value increasing in the years to come however much it rises in the interim.
Good luck to us!
Unfortunately no sellers. Because there's definitely buyers out there... MM's don't want to go short on this either. Stalemate for now, give it a bit of time - all very early days.
Simply not to be! One day :)
First for once!
hmm, an unexpected move after fairly flat trading. Just a matter of time here though, massively exciting company to be in. Seeing as if you're in here, I would recommend you take a look at REDX which IPO's on Friday. Exceptional little business, no stock left with brokers though, will be an open market buy. Sorry for that o/t, I'm not trying to ramp it (I only got a small amount myself sadly), genuinely think holders here will like it.
These are the guys I was directly referring to in my posts the other day for the TR-1. If not for them this would've been a much smaller placing, they wanted in and a slice of the pie worthwhile to someone of their size. Great all holders and hopefully now the placing price is in better context by the end of the week. It's been eaten up already and there's a lot more upward trajectory on this curve. Have a great weekend all, P
Interesting viewpoint, thanks for posting. Will look at that. When you say EFH, do you mean EKF Diagnostics which would make more sense to me? If not, can you explain EFH, I'm still learning the full story here. thanks
Thanks for the feedback, the numbers in my note (45m shares, £40m mcap) was all pre-placing shares. Thanks Nickzip, nice to see you and hope we have more luck here! Watching the interview earlier reminded me of something I had intended to mention earlier but forgot ref the 65p placing. When the book was opened on this 65p was only around 9-10% discount which was not a huge discount considering who came in and the chunky money on the table. The price has come up quick and makes the discount seem exaggerated, but these things are decided at the broker roadshows well before it filters through to the announcement as today. Expect a TR-1 here in the next day or two which hopefully will be very exciting and be another driver on the SP. Although Andrew Newland mentions 13 ii's in with this (which is great), I hear one might be very significant indeed. All the best, P
Sorry for the bombardment, but a good interview up with the MD, explains placing and how placing funds will be used: http://www.angleplc.com/angle-news/video-interview-16-feb-2015-fully-funded-for-parsortix-ovarian-cancer-care-new-partnership-with-md-anderson/
It's definitely handled the placing well today with the news. I saw quite a few sell this morning presumably in a panic over the placing price. I think once they realise this isn't going to fly down to placing price because of the MD Anderson news, they will be re-buying in and the price will see parity before continuing north. It was no doubt good sense on their part as I imagine many are sitting on healthy profit considering the rapid rise over the last 4 weeks, however this is with good cause and had it not been for the placing news I suspect we might have been trading triple figures on todays RNS. It will still come.
Thanks, I forgot to add these are EIS qualifying shares! So very tax efficient. To the poster below, I don't know the ratio for the open offer but based not he placing amount suggest it will be around 1 share for every 5 you have. It should appear in your portfolio screen with your broker, if not then just call them to enquire.
Hi, I like to put together research notes of companies I take larger position in, please find them attached. I'm new to the company and certainly not of a medical nature, so I would really welcome feedback or corrections if there is anything long termers feel I have got wrong. I hope for new potential investors this provides a basic understanding of the opportunity. https://dl.dropboxusercontent.com/u/6088200/Share%20Research/AnglePlc_Research_PoeticalTrader.pdf
Personally I don't see it going any lower and even this is a little low considering the actual action. £110k came through this morning! What I really liked about this was last week when the book was opened for the placing there were great big buys going in, with spivvy brokers in AIM you'd see this being short sold - so it was another real positive to me that good people are involved and this has only been bought into. This collaboration with MD Anderson really is a big deal, research these guys. They are very well respected and in the medical community this is a a big deal. Having a product that works is only half the battle, the other half is ensuring clinical end users (where we'll actually make our money) are aware of it - then sales will come. I'll be absolutely honest with you though, Angle already have an 'un-disclosed' pharma working with them and another now taking an interest. This is a £40m map company with a product that is likely to be worth billions in the clinical market as it can be applied so easily against most types of cancers. It can already do this, but each type of cancer has to be specifically tested for and approved. Are they going to do it alone? Are they heck, they're brilliant scientists and researchers and a large investment will be needed for the final step. At their market capitalisation they are a VERY cheap buyout for someone at several times the cost and/or a licensing deal for long term revenues. I think MD Anderson getting involved is the last step before acquisition from an existing or new relationship occurs.
That's not how it was Dan, they didn't go to market for even half what they ended up raising. They were approached by someone who wanted a significantly bigger stake and its the kind of person you want invested in your business. You have to remember this is the way they raise money, an SP going up or down doesn't make them any more money unless raising, so it's in their interests to do it at the highest price point possible. I understand how it looks on the surface and it initially put me off until I understood that. This company has a really impressive base of institutional investors and that will do it (and you) well in the future.
Good morning folks, I participated in ths as I was captivated by the story of what they're doing. In was put off by the placing price being so discounted and the way the market would read it, but believe me it's for good reasons. These guys were only looking for quite a bit less, but they're story has become so exciting they were approached by several (and one in particular) large institutions and offered a lot more as long as they could meet pricing demands. The bigger funds don't want to come in for small amounts of shares and this company is pretty much being viewed as being at the launch pad. I was also pleased to see an open offer to existing shareholders to participate. Lastly, the real big news was the MD Anderson collaboration and Angle are teaming up with some of the most reknown specialists in their field and of course specifically Ovarian cancer. This is huge news and FDA approval seems a given being as this is non-evasive. This is the precursor to not only medical acceptance, but also (for clinical purposes) recognition in the medical communitiy for sales. Mcap very good here and I very much doubt this will perform like normal discounted placings in that the SP goes down to placing. I fully expect this to end blue today once the news sinks in. All the best, P
Hi Chaps, Looks like the market has liked the new CFO with TYRU up 20% on the day and TYR lagging behind as usual (it'll get there!) Still in here and disappointed with performance obviously. Of the share price at least, I think Tyratech have done fine and do not reads the last financial update negatively. It takes a lot of money to go into retail and I see the update in June being a positive one that means these are nice prices to come in at. The TYR / TYRU is this: Tyratech have two stock lines as a result of being a US domiciled company, the un-restricted stock (TYRU) and the restricted stock (TYR). Both are in the same company, but are bought through different EPIC’s and the un-restricted stock usually shows where the restricted stock is going. Under normal market conditions the TYRU trades a little higher. For more information on un-restricted and restricted stock, please read the following on Tyratechs own website. http:// www.tyratech.com/content/investors/share_price_overview.asp !